According to the research report, the global U.S. compounding pharmacies market size is expected to touch USD 5069.56 Billion by 2027, growing with a significant CAGR of 6.5%.
The U.S. compounding pharmacies report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global U.S. compounding pharmacies in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global U.S. compounding pharmacies market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global U.S. compounding pharmacies during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1662
| Report Coverage | Details |
| Market Size by 2027 | USD 5069.56 Million |
| Growth Rate from 2020 to 2027 | CAGR of 6.5% |
| Non-sterile Segment Market Share in 2021 | 62.5% |
| Oral Medications Segment Market Share in 2021 | 51% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Pharmacy Type, Product, Sterility, Application, Compounding Type, Therapeutic Area |
This study covers a detailed segmentation
of the global U.S. compounding pharmacies market, along with key information
and a competition outlook. The report mentions company profiles of players that
are currently dominating the global U.S. compounding pharmacies market, wherein
various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Triangle compounding pharmacy
- Fagron
- B. Braun melsungen ag
- Fresenius kabi ag
- Pencol Compounding Pharmacy
- US Compounding Inc.
- Avella specialty pharmacy
- Institutional pharmacy solutions, llc
- Pharmedium services llc
- Vertisis custom pharmacy
Market Segmentation
- 503A
- 503B
By Product
- Oral
- Capsules
- Granules
- Tablets
- Powder
- Others
- Liquid Preparations
- Emulsion
- Syrup
- Solutions
- Suspension
- Others
- Topical
- Gels
- Ointments
- Creams
- Pastes
- Others
- Rectal
- Enema
- Suppositories
- Others
- Parenteral
- SVP
- LVP
- Ophthalmic
- Nasal
- Otic
By Sterility
- Sterile
- Non-Sterile
By Application
- Adult
- Geriatric
- Pediatric
- Veterinary
By Compounding Type
- Pharmaceutical Ingredient Alteration (PIA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Others
By Therapeutic Area
- Hormone replacement
- Pain management
- Dermatology
- Specialty drugs
- Nutritional supplements
- Others
Research Methodology
The research methodology adopted by
analysts for compiling the global U.S. compounding pharmacies report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global U.S. compounding pharmacies market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Therapeutic Area Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Compounding Pharmacies Market
5.1. COVID-19 Landscape: Compounding Pharmacies Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: U.S. Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Compounding Pharmacies Market, By Pharmacy Type
8.1. Compounding Pharmacies Market, by Pharmacy Type, 2022-2030
8.1.1. 503A
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. 503B
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. U.S. Compounding Pharmacies Market, By Product Type
9.1. Compounding Pharmacies Market, by Product Type, 2022-2030
9.1.1. Oral
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Liquid Preparations
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Topical
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Rectal
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Otic
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Nasal
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Ophthalmic
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. U.S. Compounding Pharmacies Market, By Sterility Type
10.1. Compounding Pharmacies Market, by Sterility Type, 2022-2030
10.1.1. Sterile
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Sterile
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. U.S. Compounding Pharmacies Market, By Application Type
11.1. Compounding Pharmacies Market, by Application Type, 2022-2030
11.1.1. Adult
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Geriatric
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Pediatric
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Veterinary
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. U.S. Compounding Pharmacies Market, By Compounding
12.1. Compounding Pharmacies Market, by Compounding, 2022-2030
12.1.1. Pharmaceutical Ingredient Alteration (PIA)
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Pharmaceutical Dosage Alteration (PDA)
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. U.S. Compounding Pharmacies Market, By Therapeutic Area
13.1. Compounding Pharmacies Market, by Product Type, 2022-2030
13.1.1. Hormone replacement
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Pain management
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Dermatology
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Specialty drugs
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Nutritional supplements
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Others
13.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 14. U.S. Compounding Pharmacies Market, Regional Estimates and Trend Forecast
14.1. U.S.
14.1.1. Market Revenue and Forecast, by Pharmacy (2017-2030)
14.1.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.3. Market Revenue and Forecast, by Sterility (2017-2030)
14.1.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.5. Market Revenue and Forecast, by Compounding (2017-2030)
14.1.6. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
Chapter 15. Company Profiles
15.1. Triangle compounding pharmacy
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Fagron
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. B. Braun melsungen ag
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Fresenius kabi ag
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Pencol Compounding Pharmacy
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. US Compounding Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Avella specialty pharmacy
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Institutional pharmacy solutions, llc
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Pharmedium services llc
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Vertisis custom pharmacy
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments